In part two of The New Daily’s survey of leading cancer research centres, we look at how personalised therapies could eclipse the one-size-fits-all approach. See more here.
In part two of The New Daily’s survey of leading cancer research centres, we look at how personalised therapies could eclipse the one-size-fits-all approach. See more here.